nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
|
Middelberg, Anton P.J. |
|
2011 |
29 |
41 |
p. 7154-7162 9 p. |
artikel |
2 |
ANNOUNCEMENT: VACCINE TECHNOLOGY IV
|
|
|
2011 |
29 |
41 |
p. 7218- 1 p. |
artikel |
3 |
Cloning and expression of protease ClpP from Streptococcus pneumoniae in Escherichia coli: Study of the influence of kanamycin and IPTG concentration on cell growth, recombinant protein production and plasmid stability
|
Einsfeldt, Karen |
|
2011 |
29 |
41 |
p. 7136-7143 8 p. |
artikel |
4 |
Editorial Board
|
|
|
2011 |
29 |
41 |
p. CO2- 1 p. |
artikel |
5 |
Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells
|
Frensing, Timo |
|
2011 |
29 |
41 |
p. 7125-7129 5 p. |
artikel |
6 |
Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: Linking systems biology with vaccine development
|
Adams, L. Garry |
|
2011 |
29 |
41 |
p. 7197-7206 10 p. |
artikel |
7 |
Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome
|
Onions, D. |
|
2011 |
29 |
41 |
p. 7117-7121 5 p. |
artikel |
8 |
Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines
|
Wei, Hung-Ju |
|
2011 |
29 |
41 |
p. 7163-7172 10 p. |
artikel |
9 |
Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography
|
Spitteler, Marcelo A. |
|
2011 |
29 |
41 |
p. 7182-7187 6 p. |
artikel |
10 |
Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine
|
Yan, Jian |
|
2011 |
29 |
41 |
p. 7173-7181 9 p. |
artikel |
11 |
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
|
Bakker, Wilfried A.M. |
|
2011 |
29 |
41 |
p. 7188-7196 9 p. |
artikel |
12 |
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
|
Camacho, A.I. |
|
2011 |
29 |
41 |
p. 7130-7135 6 p. |
artikel |
13 |
Preservative of choice for Prev(e)nar 13™ in a multi-dose formulation
|
Khandke, Lakshmi |
|
2011 |
29 |
41 |
p. 7144-7153 10 p. |
artikel |
14 |
Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero)
|
Paillet, Cristian |
|
2011 |
29 |
41 |
p. 7212-7217 6 p. |
artikel |
15 |
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A
|
Cooper, David |
|
2011 |
29 |
41 |
p. 7207-7211 5 p. |
artikel |
16 |
Vaccine stabilization: Research, commercialization, and potential impact
|
Kristensen, Debra |
|
2011 |
29 |
41 |
p. 7122-7124 3 p. |
artikel |
17 |
Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010
|
Buckland, Barry C. |
|
2011 |
29 |
41 |
p. 7115-7116 2 p. |
artikel |